European cystic fibrosis society standards of care: Quality management in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue S1, 2014, Pages

  Stern, Martin ^a   Bertrand, Dominique Pougheon ^b   Bignamini, Elisabetta ^c   Corey, Mary ^d   Dembski, Birgit ^e   Goss, Christopher H ^f   Pressler, Tanja ^g   Rault, Gilles ^h   Viviani, Laura ⁱ   Elborn, J Stuart ^j   Castellani, Carlo ^k  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b French CF QIP   (France)

^c CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e Mukoviszidose eV   (Germany)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^h National Expertise CF Center   (France)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^k UNIVERSITY HOSPITAL OF VERONA   (Italy)

more..

Author keywords

CF registries; Models of care; Outcomes in CF; Quality management; Standards

Indexed keywords

ACCREDITATION; CONSENSUS; CYSTIC FIBROSIS; DATA ANALYSIS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CENTER; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; INFORMATION SYSTEM; LEADERSHIP; NEWBORN SCREENING; PATIENT PARTICIPATION; PATIENT SATISFACTION; PEER REVIEW; PRACTICE GUIDELINE; QUALITY OF LIFE; REGISTRATION; REVIEW; TOTAL QUALITY MANAGEMENT; ADOLESCENT; ADULT; CHILD; EUROPE; FEMALE; INFANT; MALE; MEDICAL SOCIETY; NEWBORN; PRESCHOOL CHILD; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; FEMALE; HEALTH POLICY; HUMANS; INFANT; INFANT, NEWBORN; MALE; QUALITY OF HEALTH CARE; REGISTRIES; SOCIETIES, MEDICAL; STANDARD OF CARE; YOUNG ADULT;

EID: 84901058087     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.03.011     Document Type: Review

References (104)

1. DiSant'Agnese P.A. Cystic fibrosis of the pancreas. Am J Med 1956, 21:406-422.
2. Shwachman H., Kulczycki L.L. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child 1958, 96:6-15.
3. Doershuk C.F., Matthews L.W., Tucker A.S., Nudleman H., Eddy G., Wise M., et al. A 5year clinical evaluation of a therapeutic program for patients with cystic fibrosis. J Pediatr 1964, 65:677-693.
4. Warwick W.J., Pogue R.E. The prognosis for children with cystic fibrosis based on reasoned approaches to therapy: past, present, and future. J Asthma Res 1968, 5:277-284.
5. Shwachman H., Kowalski M., Khaw K.T. Cystic fibrosis: a new outlook. 70 patients above 25years of age. Medicine 1977, 56:129-149.
6. Crozier D.N. Cystic fibrosis: a not-so-fatal disease. Pediatr Clin North Am 1974, 21:935-950.
7. Gurwitz D., Corey M., Francis P.W., Crozier D., Levison H. Perspectives in cystic fibrosis. Pediatr Clin North Am 1979, 26:603-615.
8. Corey M., McLaughlin F.J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988, 41:583-591.
9. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry 2011 annual data report 2012, [Bethesda, Maryland].
10. Cystic Fibrosis Canada Canadian Cystic Fibrosis Patient Data Registry report. 2010 2011, [Toronto].
11. Cystic Fibrosis Foundation http://www.cff.org/LivingWithCF/CareCenterNetwork/QualityImprovement/.
12. Salvatore D., Buzzetti R., Baldo E., Furnari M.L., Lucidi V., Manunza D., et al. An overview of international literature from cystic fibrosis registries. Part 4: update 2011. J Cyst Fibros 2012, 11:480-493.
13. European cystic fibrosis society patient registry newsletter [Issue 3]. http://www.ecfs.eu/projects/ecfspr/newsletters.
14. The ECFS Patient Registry annual data report. 2008-2009 data. version 03 Available from:. https://www.ecfs.eu/files/webfm/webfiles/File/ecfs_registry/ECFSPR_Report0809_v32012.pdf.
15. Kerem E., Viviani L., Zolin A., Macneill S., Hatziagorou E., Ellemunter H., et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry. Eur Respir J 2013, [Epub ahead of print]. 10.1183/09031936.00166412.
16. Wiedemann B., Steinkamp G., Sens B., Stern M. The German Cystic Fibrosis Quality Assurance Project: clinical features in children and adults. Eur Respir J Eur Respir J 2001, 17:1187-1194.
17. Gutierrez H.H., Sanchez I., Schidlow D.V. Cystic fibrosis care in Chile. Curr Opin Pulm Med 2009, 15:632-637.
18. Morgan W.J., Butler S.M., Johnson C.A., Colin A.A., FitzSimmons S.C., Geller D.E., et al. Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicentre, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pumonol 1999, 28:231-241.
19. Schechter M.S. Benchmarking to improve the quality of cystic fibrosis care. Curr Opin Pulm Med 2012, 18:596-601.
20. Rosenfeld M., Emerson J., McNamara S., Joubran K., Retsch-Bogart G., Graff G.R., et al. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatr Pulmonol 2010, 45:934-944.
21. Byrnes C.A., Vidmar S., Cheney J.L., Carlin J.B., Armstrong D.S., Cooper P.J., et al. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5years of age. Thorax 2013, 68:643-651.
22. Martin B., Schechter M.S., Jaffe A., Cooper P., Bell S.C., Ranganathan S. Comparison of the US and Australian cystic fibrosis registries: the impact of newborn screening. Pediatrics 2012, 129:48-55.
23. Closing the quality gap: revisiting the state of the science series: quality improvement interventions to address health disparities. Review protocol 2011, Agency for Healthcare Research and Quality, Rockville, MD, [http://www.ahrq.gov/clinic/tp/gapdisptp.htm].
24. Berwick D.M. The science of improvement. JAMA 2008, 299:1182-1184.
25. Shojania K.G., Grimshaw J.M. Evidence-based quality improvement: the state of the science. Health Aff (Millwood) 2005, 24:138-150.
26. Berwick D.M. Continuous improvement as an ideal in health care. N Engl J Med 1989, 320:53-56.
27. Nelson E.C., Godfrey M.M., Batalden P.B., Berry S.A., Bothe A.E., McKinley K.E., et al. Clinical microsystems, Part1: The building blocks of health systems. Jt Comm J Qual Patient Saf 2008, 34:367-378.
28. Schechter M.S., Margolis P. Improving subspecialty healthcare: lessons from cystic fibrosis. J Pediatr 2005, 147:295-301.
29. Quinton H.B., O'Connor G.T., for the Northern New England CV Cystic Fibrosis Consortium Current issues in quality improvement in cystic fibrosis. Clin Chest Med 2007, 28:459-472.
30. Stern M., Wiedemann B., Wenzlaff P. From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995-2006. Eur Respir J 2008, 31:29-35. on behalf of the German Cystic Fibrosis Quality Assessment group.
31. Stern M. The use of a cystic fibrosis patient registry to assess outcomes and improve cystic fibrosis care in Germany. Curr Opin Pulm Med 2011, 17:477-573.
32. Ellemunter H., Eder J., Steinkamp G. Structured care in an ISO certified Centre for patients with cystic fibrosis and their families. Pneumologie 2011, 65:615-623.
33. Liou T.G., Elkin E.P., Pasta D.J., Jacobs J.R., Konstan M.W., Morgan W.J., et al. Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros 2010, 9:250-256.
34. Taylor-Robinson D., Whitehead M., Diderichsen F., Vebert Olesen H., Pressler T., Smyth R.L., et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 2012, 67:860-866.
35. Pillarisetti N., Williamson E., Linnane B., Skoric B., Robertson C.F., Robinson P., et al. Infection, inflammation and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011, 184:75-81.
36. Kraynack N.C., McBride J.T. Improving care at cystic fibrosis centers through quality improvement. Semin Respir Crit Care Med 2009, 30:547-558.
37. Zemanick E.T., Harris J.K., Conway S., Konstan M.W., Marshall B., Quittner A.L., et al. Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy. J Cyst Fibros 2010, 9:1-16.
38. Glauser T.A., Nevins P.H., Williamson J.C., Abdolrasulnia M., Salinas G.D., Zhang J., et al. Adherence to the 2007 cystic fibrosis pulmonary guidelines: a national survey of CF care centers. Pediatr Pulmonol 2012, 47:434-440.
39. McPhail G.L., Weiland J., Acton J.D., Ednick M., Chima A., VanDyke R., et al. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med 2010, 164:957-960.
40. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008, 108:832-839.
41. Moen I.E., Nilsson K., Andersson A., Fagerland M.W., Fluge G., Hollsing A., et al. Dietary intake and nutritional status in a Scandinavian adult cystic fibrosis population compared with recommendations. Food Nutr Res 2011, 55:7561.
42. Leonard A., Davis E., Rosenstein B.J., Zeitlin P.L., Paranjape S.M., Peeler D., et al. Description of a standardized nutrition classification plan and its relation to nutritional outcomes in children with cystic fibrosis. J Pediatr Psychol 2010, 35:6-13.
43. Stark L.J., Opipari-Arrigan L., Quittner A.L., Bean J., Powers S.W. The effects of an intensive behavior and nutrition intervention compared to standard of care on weight outcomes in CF. Pediatr Pulmonol 2011, 46:31-35.
44. Davis P.B. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006, 173:475-482.
45. CF Europe http://www.cf-europe.eu/.
46. Cystic Fibrosis Foundation Patient Registry 2011 Annual Data Report 2011, Cystic Fibrosis Foundation, Bethesda, Maryland, [http://www.cff.org/research/ClinicalResearch/PatientRegistryReport].
47. Goss H.G., Quittner A.L. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007, 4:378-386.
48. Mayer-Hamblett N., Ramsey B.W., Kronmal A.K. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc Am Thorac Soc 2007, 4:370-377.
49. European Medicines Agency Committee for medicinal products for Human Use (CHMP). Guidelines on the Clinical Development of Medicinal Products for the Treatment of Cystic Fibrosis Oct. 22 2009, [London, http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/12/WC500017055.pdf].
50. Kerem E., Conway S., Elborn S., Heijerman H., for the Consensus Committee Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4(7-26):20.
51. Steinkamp G., Schwarz C., Stahl K., Busche M.C.F. Care through the patient's eyes - a nationwide survey on patients' experience and satisfaction with services using a CF-specific questionnaire. Pediatr Pulmonol 2012, 47(S35):404. (abstract 492).
52. Quon B.S., Goss C.H. A story of success: continuous quality improvement in cystic fibrosis care in the USA. Thorax 2011, 66:1106-1108.
53. http://www.cftrust.org.uk/aboutus/annualreview/CF_Trust_Annual_Review_2011_%28web%29.pdf.
54. https://www.cysticfibrosis.org.uk/media/82070/CD_Standards_of_Care_Dec_11.pdf.
55. http://www.cff.org/treatments/CFCareGuidelines/AgeSpecificCare/.
56. Batalden P.B., Davidoff F. What is "quality improvement" and how can it transform healthcare?. Qual Saf Health Care 2007, 16:2-3.
57. Sermet-Gaudelus I., Mayell S.J., Southern K.W. Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibros 2010, 9:323-329.
58. Mehta G., Macek M., Mehta A., European Registry Working Group Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 2010, 9(Suppl. 2):5-21.
59. World Health Organization Guidance on developing quality and safety strategies with a health system approach 2008, World Health Organization Regional Office for Europe, Copenhagen.
60. Stern M., Niemann N., Wiedemann B., Wenzlaff P., German CFQA Group Benchmarking improves quality in cystic fibrosis care: a pilot project involving 12 Centres. Int J Qual Health Care 2011, 23:349-356.
61. Ayers L.R., Beyea S.C., Godfrey M.M., Harper D.C., Nelson E.C., Batalden P.B. Quality improvement learning collaboratives. Qual Manag Health Care 2005, 14:234-247.
62. Rault G., Pougheon-Bertrand D., Gueganton L., Minguet G., Lombrail P. CF quality improvement program: a pilot phase to experiment the US QIP approach in France. Poster; ECFS Conference, Dublin, Ireland June 6-9 2012.
63. Schechter M.S., Leonard A., Nash J., Quinton H., Richards K., Sabadosa K., et al. Benchmarking: signature themes. Pediatr Pulmonol 2006, (Suppl. 29):122-123.
64. Homchick R.G., Hayward L.R. Chapter 16. Peer review and quality assurance requirements 2009, Washington Health Law Manual. 3rd ed. D.W. Tremaine, JD Organization (Eds.).
65. World Health Organization Quality of care: a process for making strategic choices in health systems 2006, World Health Organization, Geneva.
66. Nelson E.C., Batalden P.B., Godfrey M. Measurement and monitoring. Quality by design: a clinical microsystems approach 2007, John Wiley & Sons, Hoboken, NJ.
67. McIntyre K., Shojania K.G. The challenges of quality improvements reports and the urgent need for more of them. Thorax 2011, 66:1020-1022.
68. Shaw C.D., Kalo I. A background for national quality policies in health systems 2002, World Health Organization Regional Office for Europe, Copenhagen.
69. Kulich M., Rosenfeld M., Goss C.H., Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr 2003, 142:631-636.
70. Mayer-Hamblett N., Rosenfeld M., Emerson J., Goss C.H., Aitken M.L. Developing cystic fibrosis lung transplant referral criteria using predictors of two year mortality. Am J Respir Crit Care Med 2002, 166:1550-1555.
71. Dasenbrook E.C., Checkley W., Merlo C.A., Konstan M.W., Lechtzin N., Boyle M.P. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010, 303:2386-2392.
72. Quon B.S., Mayer-Hamblett N., Aitken M.L., Smyth A.R., Goss C.H. Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med 2011, 184:1147-1152.
73. Smyth A., Lewis S., Bertenshaw C., Choonara I., McGaw J., Watson A. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 2008, 63:532-535.
74. Chamnan P., Shine B.S., Haworth C.S., Bilton D., Adler A.I. Diabetes as a determinant of mortality in cystic fibrosis. Diabetes Care 2010, 33:311-316.
75. Johnson C., Butler S.M., Konstan M.W., Morgan W., Wohl M.E. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003, 123:20-27.
76. Döring G., Flume P., Heijerman H., Elborn J.S. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 2012, 11:461-479.
77. Schechter M.S., Gutierrez H.H. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr 2010, 22:296-301.
78. Kraynack N.C., Gothard M.D., Falletta L.M., McBride J.T. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers. Pediatr Pulmonol 2011, 46:870-881.
79. Mott L.S., Park J., Murray C.P., Gangell C.L., de Klerk N.H., Robinson P.J., et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012, 67:509-516.
80. Sanders D.B., Lai H.J., Rock M.J., Farrell P.M. Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies. J Cyst Fibros 2012, 11:150-153.
81. Calvin J., Hogg S.L., McShane D., McAuley S.A., Iles R., Ross-Russell R., et al. Thirty-years of screening for cystic fibrosis in East Anglia. Arch Dis Child 2012, 97:1043-1047.
82. Vernooij-van Langen A.M., Loeber J.G., Elvers B., Triepels R.H., Gille J.J., Van der Ploeg C.P., et al. Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study. Thorax 2012, 67:289-295.
83. Walshe K. International comparisons of the quality of health care: what do they tell us?. Qual Saf Health Care 2003, 12:4-5.
84. Dreachslin J.L., Zernott M., Mendenhall S., Nieuwenjuijsen E.R. Data comparability issues in international research and quality assurance. Qual Assur Health Care 1993, 5:143-156.
85. Quality of care for general medical conditions: a review of the literature and quality indicators 2000, RAND Corporation, Santa Monica, CA. E.A. Kerr, S.M. Asch, E.G. Hamilton, E.A. McGlynn (Eds.).
86. Marshall M.N., Shekelle P.G., McGlynn E.A., Campbell S., Brook R.H., Roland M.O. Can health care quality indicators be transferred between countries?. Qual Saf Health Care 2003, 12:8-12.
87. Ellis J. Sharing the evidence: clinical practice benchmarking to improve continuously the quality of care. J Adv Nurs 2000, 32:215-225.
88. Goddard M., Mannion R., Smith P. Enhancing performance in health care: a theoretical perspective on agency and the role of information. Health Econ 2000, 9:95-107.
89. Sims G. International benchmarking from Centre level cystic fibrosis data. Pediatr Pulmonol 2010, 45(S33):527.
90. Conway S., Balfour-Lynn I.M., De Rijcke K., Drevinek P., Foweraker J., Havermans T., et al. European Cystic Fibrosis Society Standards of Care: framework for the cystic fibrosis centre. J Cyst Fibros 2014, 13:3-22.
91. Gawande A. The bell curve. N Y Ann Med 2004, The New Yorker.
92. Delaisi B., Grosskopf C., Reignault E., Goehrs J.M., Navarro J. International registry on mucoviscidosis: comparison of the French data with the European data for 1995. Arch Pediatr 1998, 5:384-388.
93. Lai H.C., Corey M., FitzSimmons S., Kosorok M.R., Farrell P.M. Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr 1999, 69:531-538.
94. Fogarty A., Hubbard R., Britton J. International comparison of median age at death from cystic fibrosis. Chest 2000, 117:1656-1660.
95. Koch C., Cuppens H., Rainisio M., Madessani U., Harms H., Hodson M., et al. European Epidemiologic Registry of Cystic Fibrosis (ERCF): comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001, 31:1-12.
96. McCormick J., Mehta G., Olesen H.V., Viviani L., Macek M., Mehta A., et al. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010, 375:1007-1013.
97. Knudsen P.K., Olesen H.V., Høiby N., Johannesson M., Karpati F., Laerum B.N., et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis Centres in Denmark, Norway and Sweden. J Cyst Fibros 2009, 8:135-142.
98. Jackson A.D., Daly L., Kelleher C., Marshall B.C., Quinton H.B., Foley L., et al. The application of current life table methods to compare cystic fibrosis median survival internationally is limited. J Cyst Fibros 2011, 10:62-65.
99. Boelle P.Y., Viviani L., Busson P.F., Olesen H., Ravilly S., Stern M., et al. Reference percentiles for FEV1 and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis 2012, 7:64.
100. Viviani L., Zolin A., Olesen H.V. ECFSPR Annual Report 2008-2009 2012, European Cystic Fibrosis Society Patient Registry.
101. McCormick J., Sims E.J., Green M.W., Mehta G., Culross F., Mehta A. Comparative analysis of Cystic Fibrosis Registry data from the UK with USA, France and Australasia. J Cyst Fibros 2005, 4:115-122.
102. Sims G. International benchmarking for cystic fibrosis patient outcomes using registry data. J Cyst Fibros 2009, 8(S2):S103.
103. Cystic fibrosis data network http://www.cysticfibrosisdata.org/metadata-and-methodology.htm.
104. Sims G. Outline and proposal for an international Cystic Fibrosis Data Network http://www.cfww.org/programs/article/1319/Outline_and_proposal_for_an_international_Cystic_Fibrosis_Data_Network_April_2010.